Sponsor Pipeline

Leslie Kean Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT06991361
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory…		 Recruitment opened
2026-07-24 NCT06991361
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory…		 date change Primary completion pushed: 2028-12-01 -> 2029-05-01
2026-07-24 NCT06991361
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory…		 date change Completion pushed: 2030-12-01 -> 2031-05-01
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06991361 Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory… Graft Versus Host Disease (cGvHD) Recruiting
Get alerts when Leslie Kean's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free